http://www.medscape.com/SCP/IIM/2001/v18.n02/m1802.08.estr/m1802.08.estr.html
|
|
From Pediatric Bulletin Benjamin Estrada, MD, University of South Alabama,
Mobile. [Infect
Med 18(2):77-78, 2001. © 2001 Cliggott Publishing Co., Division of
SCP/Cliggott Communications, Inc.] During the last 4 decades, there has been significant progress toward the
eradication of poliomyelitis. The first inactivated poliovirus vaccine was
introduced shortly after epidemic poliomyelitis reached its peak in the
United States during the 1950s. The subsequent development of oral poliovirus
vaccine (OPV) containing attenuated virus had a significant impact on public
health worldwide. Combined efforts of the World Health Organization (WHO) and
the ministries of health of many countries have led to massive immunization
campaigns that have been successful in significantly decreasing the global
prevalence of this disease. One of the WHO's top priorities was the worldwide eradication of this
infection by the year 2000. Although substantial progress toward this goal
has been made, poliomyelitis remains endemic in some countries. A geographic
area of concern is the eastern Mediterranean region, which includes Pakistan
and Afghanistan. Sixty percent of all acute flaccid paralysis cases reported
to the WHO in 1999 occurred in Pakistan.[1]
Poliomyelitis continues to be endemic in some areas in West Africa; this is
evidenced by a recently reported outbreak in Cape Verde that included 33
cases, some of which had associated mortality.[2] In addition, vaccine coverage remains low in central
Africa -- only 40% in 1999.[3]
In 1991, the Western Hemisphere had been declared free of poliomyelitis.
However, the Pan-American Health Organization (PAHO) recently reported a
poliomyelitis outbreak in Haiti and the Dominican Republic. Six virologically
confirmed cases of poliomyelitis have occurred in the Dominican Republic
since July 12, 2000, and 16 additional persons have manifested symptoms of
this disease. One case has been virologically confirmed in Haiti. According
to the CDC, the age range of persons with reported cases has been 9 months to
21 years, with most cases in children younger than 6 years. All patients were
either inadequately vaccinated or unvaccinated. The governments of both
countries have continued active surveillance in search of additional cases.
According to the PAHO, the virus isolated in this outbreak is 97% similar to
the Sabin type 1 virus contained in poliovirus vaccine and probably
originated from it. This is now a wild virus, believed to have been in
circulation for about 2 years. Previous experience has shown that prolonged
circulation of OPV virus in areas with low coverage may trigger disease
outbreaks. Efforts to complete mass immunization campaigns are under way in
both countries.[4,5] The outbreak in the Dominican Republic and Haiti comes as a surprise,
since this area of the world had been certified as being free of
poliomyelitis for several years. The importance of continuous surveillance
and high immunization coverage needs to be emphasized until global
eradication is achieved, even in those countries where transmission is
considered less likely. Children traveling to areas where poliomyelitis is
endemic or to countries where recent outbreaks have been reported should be
current on their poliovirus immunization according to the schedule
recommended by the American Academy of Pediatrics.[6] Most persons older than 18 years in
the United States who have not been vaccinated or whose immunization status
is unknown should receive inactivated poliovirus vaccine. The recommended
immunization schedule for adults includes administration of the first 2 doses
1 to 2 months apart and a third dose 6 to 12 months after the second.[7] References
Dr Estrada is assistant professor of pediatrics, division
of pediatric infectious diseases, University of South Alabama, Mobile. |
|
|
|
|||||
|
All material on this
website is protected by copyright. Copyright ©
1994-2001 by Medscape Inc. All rights reserved. This website also contains
material copyrighted by 3rd parties. Medscape requires 3.x browsers or better
from Netscape or Microsoft.
ALL
INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR
GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE
KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED
AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO
VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU
ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.